Neogen (NEOG) Depreciation & Amortization (CF) (2010 - 2026)
Neogen (NEOG) posted quarterly Depreciation & Amortization (CF) of $29.4 million for Q2 2026, down 2.97% year-over-year from $30.3 million in Q2 2025, and up 1.73% quarter-over-quarter from $28.9 million in Q1 2026.
Neogen (NEOG) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Neogen's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $29.4 million for Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) fell 2.97% year-over-year to $29.4 million; the TTM figure through May 2026 stood at $116.3 million (down 2.73% YoY), while the FY2026 annual figure was $116.3 million, down 2.68% from the prior year.
- Depreciation & Amortization (CF) for Q2 2026 stood at $29.4 million, up from $28.9 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $30.3 million in Q2 2025, with the low at $5.7 million in Q3 2022.
- The 5-year median for Depreciation & Amortization (CF) is $28.9 million (2025), against an average of $25.2 million.
- The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) surged 401.55% in 2023, then dropped 3.73% in 2025.
- Neogen's Depreciation & Amortization (CF) stood at $26.7 million in 2022, then rose by 10.21% to $29.5 million in 2023, then increased by 1.96% to $30.0 million in 2024, then dropped by 3.73% to $28.9 million in 2025, then rose by 1.64% to $29.4 million in 2026.
- Business Quant data shows NEOG's Depreciation & Amortization (CF) at $29.4 million in Q2 2026, $28.9 million in Q1 2026, and $28.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Neogen | 2.56 Bn | 2.37 Bn | 107.80 Mn | 29.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 29.40 Mn |
| May 31, 2026 | 29.40 Mn |
| Feb 28, 2026 | 28.90 Mn |
| Feb 28, 2026 | 28.90 Mn |
| Nov 30, 2025 | 3.35 Mn |
| Nov 30, 2025 | 3.35 Mn |
| Aug 31, 2025 | 29.06 Mn |
| Aug 31, 2025 | 29.06 Mn |
| May 31, 2025 | 30.28 Mn |
| May 31, 2025 | 30.28 Mn |
| Feb 28, 2025 | 29.40 Mn |
| Feb 28, 2025 | 29.40 Mn |
| Nov 30, 2024 | 30.05 Mn |
| Nov 30, 2024 | 30.05 Mn |
| Aug 31, 2024 | 29.80 Mn |
| Aug 31, 2024 | 29.80 Mn |
| May 31, 2024 | 28.86 Mn |
| May 31, 2024 | 28.86 Mn |
| Feb 29, 2024 | 29.65 Mn |
| Feb 29, 2024 | 29.65 Mn |